Saturday, December 27, 2014 Last update: 6:33 AM - Covering Large & Obscure Tech Companies Since 1996

Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference

Companies mentioned in this article: Array BioPharma

BOULDER, Colo., Sept. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

    Event:     Morgan Stanley 2014 Global Healthcare Conference

    Presenter: Ron Squarer, Chief Executive Officer

    Date:      Wednesday, September 10, 2014

    Time:      12:55 p.m. Eastern Time

    Location:  Grand Hyatt New York


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to

    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.



Logo -

SOURCE Array BioPharma